Workflow
Nelson: Seeing "Same Red Flags" in TSLA, Signals Pending Pullback
Youtube· 2025-09-22 15:30
Joining us now very pleased to say is Garrett Nelson, vice president and senior equity analyst, CFRA research, who actually downgraded Tesla to sell last week with a $300 price target. Uh Garrett, let's just get over to you and I'm just wondering exactly what was behind that call. >> Yeah, thanks for having me.In our view, earnings expectations are too high surrounding the name. Um and so it's a mix of expectations being too high and then valuation. uh the stock is now trading well north of 200 times our EP ...
Peter Thiel-Backed Avantis ($AVNT) Soars 77% on Binance and Coinbase Listings, $10M Airdrop
Yahoo Finance· 2025-09-22 15:28
The cryptocurrency token Avantis (AVNT), backed by billionaire investor Peter Thiel, has surged as much as 77% over the past week.| Credit: Nordin Catic / Getty Images. Key Takeaways Avantis ($AVNT) surged 77% in a week after being simultaneously listed on major exchanges. A fully unlocked $10 million airdrop, equal to 12.5% of total supply, fueled retail participation. After hitting an all-time high of $2.66, AVNT pulled back to $2.05. The cryptocurrency token Avantis (AVNT), backed by billionair ...
Due Diligence Concluded / Commencement of Definitive Agreement
Prnewswire· 2025-09-22 15:28
VANCOUVER, BC , Sept. 22, 2025 /PRNewswire/ -- Lithium South Development Corporation (the "Company" or "Lithium South") (TSX-V: LIS) (OTCQB: LISMF) (Frankfurt: OGPQ) ) is providing an update to its news release of July 30, 2025 and August 7, 2025 regarding the sale of the Hombre Muerto North Lithium Project property package to POSCO Argentina SAU, which is the 100-per-cent owned Argentine subsidiary of POSCO Holdings Inc. ("POSCO'), referred to as the Transaction. ...
Pfizer: Metsera Acquisition Is The Missing Piece Of The Obesity Puzzle (NYSE:PFE)
Seeking Alpha· 2025-09-22 15:27
I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up to Growth Stock Forum.Pfizer Inc. (NYSE: PFE ) announced today that it will acquire Metsera, Inc. (NASDAQ: MTSR ...
Oil Price News: Bearish Fed Outlook, OPEC Demand Optimism, and Spec Position Shifts
FX Empire· 2025-09-22 15:27
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Will the FDA's Nod for Subcutaneous Keytruda Ease Merck's Headwinds?
ZACKS· 2025-09-22 15:26
Key Takeaways Merck won FDA approval for a subcutaneous version of Keytruda, covering most solid tumor uses.The SC form takes as little as one minute to administer, versus at least 30 minutes for IV.Approval arrives as Keytruda faces 2028 patent expiry, with SC patents extending protection.Merck (MRK) announced that the FDA has approved the subcutaneous (under the skin or SC) formulation of its blockbuster PD-L1 inhibitor, Keytruda (pembrolizumab). This version, which will be marketed as Keytruda Qlex, is a ...
Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?
ZACKS· 2025-09-22 15:26
Amgen (AMGN) shares soared 3.5% in the last trading session to close at $285.41. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.7% loss over the past four weeks.Amgen’s shares climbed likely after the advisory committee to the European Medicine Agency recommended expanding Uplizna’s use to treat adult patients with active immunoglobulin G4-related disease, a rare autoimmune condition with no approved therapies in the EU. Phase ...
Will Corning's Focus on Cover Materials, Glass Substrate Stoke Growth?
ZACKS· 2025-09-22 15:26
Key Takeaways Corning expands durable cover materials with Gorilla Glass Ceramic for stronger device protection.GLW launches Gorilla Glass Ceramic 2 with embedded crystals to boost toughness and transparency.Corning's Gen 10 glass substrates cut costs, enhance display quality and serve rising LCD demand.Corning Incorporated (GLW) is focusing on expanding its portfolio of durable cover materials to gain a competitive advantage against rivals. The Corning Gorilla Glass Ceramic boasts an advanced protective la ...
CWB: Rate Cuts Mostly Benefit Large-Cap Tech
Seeking Alpha· 2025-09-22 15:26
Thanks to our global coverage we've ramped up our global macro commentary on our marketplace service here on Seeking Alpha, The Value Lab . We focus on long-only value ideas, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value-investor, serious about protecting your wealth, us at the Value Lab might be of inspiration.They le ...
NiftyIT Index slumps 3% on new US visa fee
BusinessLine· 2025-09-22 15:25
Information technology stocks were the worst performers on Monday, with the Nifty IT index plunging 3 per cent and over $10 billion erosion in market capitalisation, as over the weekend the US imposed a stiff $100,000 fee on new H-1B application, potentially raising costs for Indian IT companies sending workers abroad. IT stocks, with the second heaviest weightage in the benchmark Nifty50, saw losses in the range 1.7 to 3 per cent. In the NiftyIT index, losses were in the range of 1.7 to 4.7 per cent, with ...